Membrion Stock

A Seattle, WA-based manufacturer of ultra-low cost, high performance ion exchange membranes.

Sign up today and learn more about Membrion Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Membrion Stock

Membrion™ is a 2016 spin-out from the laboratories of the University of Washington (UW). Commercialization funding from the UW, the Murdock Charitable Trust, Amazon, the National Science Foundation (Award #1648517) and a consortium of California utilities (Rocket Fund) has helped to bridge the translation gap to a commercial product. In total, 11 different funding organizations have evaluated and financially supported Membrion's product development and commercialization plan. Most recently, that support has translated to private investment by angel investors as they scale their technology into commercial production.

Funding History

September 2018$748K
September 2018$1.0M
December 2018$485K
February 2019$3.1M



Greg Newbloom

President & CEO

John Plaza


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: